During the past decade, Rush University Children's Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rush University Children's Hospital" #1 sponsor was "ACADIA Pharmaceuticals Inc." with 1 trials, followed by "Boston Children's Hospital" with 1 trials sponsored, "Catabasis Pharmaceuticals" with 1 trials sponsored, "NYU Langone Health" with 1 trials sponsored and "Ohio State University" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush University Children's Hospital" #1 collaborator was "American Academy of Pediatrics" with 1 trials as a collaborator, "Angelman Syndrome Biomarker & Outcome Measure Consortium (A-BOM)" with 1 trials as a collaborator, "Angelman Syndrome Foundation, Inc." with 1 trials as a collaborator, "Canadian Angelman Syndrome Society" with 1 trials as a collaborator and "Food and Drug Administration (FDA)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Rush University Children's Hospital" are "ADH Inappropriate" (1 trials), "AVB - Atrioventricular Block" (1 trials), "Angelman Syndrome" (1 trials), "Fetal AVB" (1 trials) and "Fluid and Electrolyte Imbalance" (1 trials). Many other conditions were trialed in "Rush University Children's Hospital" in a lesser frequency.

Most popular intervention types in "Rush University Children's Hospital" are "Drug" (3 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Active Control" (1 trials), "Coaching calls" (1 trials), "Dexamethasone" (1 trials) and "Edasalonexent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rush University Children's Hospital" are 3 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rush University Children's Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Rush University Children's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rush University Children's Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".